Results 281 to 290 of about 208,281 (313)
Some of the next articles are maybe not open access.

CRKL Binding to BCR-ABL and BCR-ABL Transformation

Leukemia & Lymphoma, 1999
The SH2-SH3 domain-containing adaptor protein CRKL is the predominant tyrosine phosphorylated protein in chronic myelogenous leukemia (CML) neutrophils and BCR-ABL-expressing cell lines. The amino terminal CRKL SH3 domain binds directly to a proline-rich region in the C-terminus of BCR-ABL. BCR-ABL mutants with deletions of this region were constructed
Brian J. Druker   +4 more
openaire   +3 more sources

Malignant transformation by abl and BCR/ABL

1993
Activated abl oncogenes have been implicated in causing pre-B lymphoma in mice via Abelson murine leukemia virus, fibrosarcoma in cats via Hardy-Zuckerman feline sarcoma virus II, and, through the Philadelphia chromosome, are linked with the myeloproliferative syndrome chronic myelogenous leukemia and with acute lymphoid and myeloid leukemia in humans.
openaire   +3 more sources

Ablative and Non-ablative Fractional Resurfacing

2012
Fractionated laser resurfacing leads to improvement of photodamaged skin, rhytides and acne scars. In contrast to non-fractionated ablative laser resurfacing, fractionated ablative laser resurfacing is associated with lower risk of complications and less downtime.
David H. Ciocon   +3 more
openaire   +2 more sources

Regulation of the c-Abl and Bcr–Abl tyrosine kinases

Nature Reviews Molecular Cell Biology, 2004
The prototypic non-receptor tyrosine kinase c-Abl is implicated in various cellular processes. Its oncogenic counterpart, the Bcr-Abl fusion protein, causes certain human leukaemias. Recent insights into the structure and regulation of the c-Abl and Bcr-Abl tyrosine kinases have changed the way we look at these enzymes.
Oliver Hantschel, Giulio Superti-Furga
openaire   +3 more sources

Biology of BCR-ABL

Blood Reviews, 1999
gene on chromosome 9 is the humanhomologue of a gene originally identified in a murineoncogenic virus, the Abelson murine leukaemia virus(A-MuLV). This retrovirus was isolated from a pred-nisolone treated mouse which developed lymphomafollowing innoculation with Moloney murineleukaemia virus (M-MuLV).
Qingqiu Pu   +2 more
openaire   +3 more sources

Complications of Fractional Lasers (Ablative and Non-ablative)

2016
Fractionated laser technology has allowed physicians to minimize downtime and complications increasing the number of treatments with lower rate of complications than non-fractionated laser treatment, especially for eyelid and perioral region treatments.
Norma Cameli, Maria Mariano
openaire   +2 more sources

BCR/ABL and leukemia

Leukemia Research, 1996
This review focuses on the role of the chimeric BCR/ABL gene in leukemia development. First, we discuss and update knowledge regarding the molecular biology of BCR/ABL. We then review data regarding transforming activity of BCR/ABL. Third, we discuss the complex interactions between BCR/ABL and leukemia phenotype. We conclude with a brief discussion of
Anna Butturini   +2 more
openaire   +3 more sources

On not being able to dream

The International Journal of Psychoanalysis, 2003
In this paper, the author explores the phenomenon of not being able to dream (as opposed to not being able to remember one's dreams) from three different vantage points. First, from the point of view of psychoanalytic theory, he discusses Bion's idea that the work of dreaming creates the conscious and unconscious mind (and not the other way around).
openaire   +3 more sources

The Immunology of Ablative Radiation

Seminars in Radiation Oncology, 2015
Radiation has been a staple of cancer therapy since the early 20th century and is implemented in nearly half of current cancer treatment plans. Originally, the genotoxic function of radiation led to a focus on damage and repair pathways associated with deoxyribonucleic acid as important therapeutic targets to augment radiation efficacy.
Byron Burnette, Ralph R. Weichselbaum
openaire   +3 more sources

Ablative Light Sources

Applied Optics, 1968
Electrical and optical properties of ablative light sources are discussed. For the range of parameters studied, the energy balance shows that it is possible to obtain approximately one-third of the energy delivered to the lamp as radiative energy (in the 0.35-1.1-micro band); two-thirds are used in the buildup processes of the discharge.
W. P. Rahilly, Rudolph G. Buser
openaire   +3 more sources

Home - About - Disclaimer - Privacy